| Oct 2 |
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
|
| Sep 24 |
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
|
| Sep 20 |
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
|
| Sep 17 |
Microsoft, Intel And 3 Stocks To Watch Heading Into Tuesday
|
| Aug 1 |
Nutriband (NASDAQ:NTRB investor five-year losses grow to 80% as the stock sheds US$27m this past week
|
| Jul 19 |
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
|
| Jul 15 |
Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology
|
| Jun 20 |
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
|
| Jun 3 |
Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
|
| May 21 |
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30
|
